
How NMOSD and MS are Impacted by COVID-19 Infection and Vaccination - Neuromyelitis Optica Spectrum Disorder
COVID-19 infection and COVID-19 vaccination were associated with a mild increase in risk of relapse among patients with multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD). That was the conclusion—with some caveats—of a team of researchers from the Czech Republic, who recently tapped a nationwide database to conduct a retrospective, observational cohort study.1
“We aimed to evaluate the short-term risks of clinical relapse in the 90-day period after the first dose [of] CO
“We aimed to evaluate the short-term risks of clinical relapse in the 90-day period after the first dose [of] CO